| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Dec 2022 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 999.30M | 971.99M | 912.05M | 856.34M | 546.04M |
| Gross Profit | 273.18M | 251.69M | 186.51M | 199.25M | 106.53M |
| EBITDA | 121.20M | 137.55M | 123.08M | 146.06M | 70.65M |
| Net Income | 39.49M | 49.16M | 52.14M | 77.38M | 30.00M |
Balance Sheet | |||||
| Total Assets | 742.96M | 795.70M | 679.86M | 618.14M | 524.87M |
| Cash, Cash Equivalents and Short-Term Investments | 130.48M | 197.41M | 123.33M | 115.81M | 109.00M |
| Total Debt | 382.15M | 384.09M | 323.44M | 272.32M | 272.60M |
| Total Liabilities | 587.94M | 573.04M | 498.75M | 453.46M | 428.04M |
| Stockholders Equity | 155.02M | 222.66M | 181.12M | 164.68M | 96.83M |
Cash Flow | |||||
| Free Cash Flow | 95.04M | 79.15M | 58.18M | 78.16M | 41.28M |
| Operating Cash Flow | 102.81M | 86.52M | 65.06M | 82.30M | 43.96M |
| Investing Cash Flow | -22.06M | -16.84M | -63.70M | -44.48M | -52.80M |
| Financing Cash Flow | -136.18M | 9.86M | -6.68M | -28.31M | 13.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | €587.07M | 13.07 | 13.18% | 2.65% | 1.76% | -18.57% | |
69 Neutral | €603.67M | 14.15 | 21.61% | ― | 15.81% | 63.97% | |
65 Neutral | €784.59M | 23.37 | 6.15% | 3.78% | 0.21% | 33.16% | |
62 Neutral | €624.83M | 24.19 | 13.51% | 1.43% | 7.30% | -15.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | €526.45M | 7.59 | 28.91% | 1.29% | 2.04% | 14.78% | |
56 Neutral | €387.78M | 40.26 | 12.82% | 0.85% | 13.29% | 214.17% |